UltramicroELISA for measuring tetanus antitoxin in human sera. 1996

E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
Carlos J. Finlay Biologicals Production Company, Havana, Cuba.

This article describes a combination of methods--a solid-phase enzyme-linked immunosorbent assay (ELISA) combined with an ultramicroanalytical system (UMAS)--that can be used to measure tetanus antitoxin activity in human sera or plasma. The test, which is rapid and permits analysis of 78 samples of serum per reaction plate with a volume of 10 microL of diluted serum per sample, is proposed as an alternative to the traditional biologic assay in mice based on seroneutralization of a known dose of tetanus toxin. The study reported here compared these two procedures, using them both to evaluate 100 sera from the Clinical Laboratory of the General Calixto García Hospital in Havana, Cuba. The two sets of results showed a high degree of correlation (r = 0.99) when subjected to linear regression analysis (95% CI = 0.985-0.993). These and other findings indicate that the cheap and rapid ultramicroELISA method can perform certain tasks for which the slower and costlier traditional assay is not well suited, such as field evaluation of tetanus toxoid vaccines and identification of hyperimmune plasmas appropriate for use in producing specific antitetanus immunoglobulin.

UI MeSH Term Description Entries
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016014 Linear Models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression. Linear Regression,Log-Linear Models,Models, Linear,Linear Model,Linear Regressions,Log Linear Models,Log-Linear Model,Model, Linear,Model, Log-Linear,Models, Log-Linear,Regression, Linear,Regressions, Linear

Related Publications

E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
July 1987, Journal of biological standardization,
E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
June 1979, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology,
E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
January 1957, Medical technicians bulletin,
E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
April 1987, Journal of biological standardization,
E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
April 1963, British medical journal,
E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
January 1968, British medical journal,
E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
January 1967, New York state journal of medicine,
E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
September 1966, Canadian Medical Association journal,
E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
September 1966, Canadian Medical Association journal,
E M Fajardo, and J L Fernández, and R L Solís, and B Portuondo, and L Heredia, and M Noroña, and H Urquiza, and M Amat
January 1974, Lancet (London, England),
Copied contents to your clipboard!